These data suggest that tumour cells with mtp53 can evolve alternative mechanisms of escape from immune surveillance: upregulation of immune checkpoints in tumours with high IFN signalling or downregulation of IFN signalling. This evidence concerns the gene IFNA1 and neoplasm.